fig2

Figure 2. The putative cell-specific effects and signaling pathways of CCL17 in atherosclerosis, peripheral artery disease, cardiovascular disease, ischemic stroke, and kidney disease. Key participants include CCL17-producing/target cells (dendritic cells, Treg, CD4⁺T, macrophages, Th1/Th2/Th17 cells) and chemokine-receptor pairs (CCL17/CCL3; CCR4/CCR1/CCR8) mediating intercellular crosstalk. Created in BioRender. YAN, W. (2025) https://BioRender.com/1opgqm0.